Variant report
Variant | nsv980987 |
---|---|
Chromosome Location | chr5:92442201-92446772 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554953345 | chr5:92442210-92442211 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs374471276 | chr5:92442220-92442221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574921943 | chr5:92442280-92442281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564864369 | chr5:92442366-92442367 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543539438 | chr5:92442370-92442371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs367890735 | chr5:92442373-92442374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563938952 | chr5:92442383-92442384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs532620791 | chr5:92442390-92442391 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545955563 | chr5:92442411-92442412 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187631069 | chr5:92442482-92442483 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559630516 | chr5:92442487-92442488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528715390 | chr5:92442522-92442523 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547828991 | chr5:92442534-92442535 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560220019 | chr5:92442555-92442556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532129480 | chr5:92442581-92442582 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192797971 | chr5:92442585-92442586 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs184344987 | chr5:92442631-92442632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550383582 | chr5:92442632-92442633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs570499172 | chr5:92442668-92442669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539659899 | chr5:92442715-92442716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553162823 | chr5:92442722-92442723 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144645385 | chr5:92442727-92442728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1353494 | chr5:92442766-92442767 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs555040431 | chr5:92442767-92442768 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574724234 | chr5:92442768-92442769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112789756 | chr5:92442924-92442925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs543922432 | chr5:92442957-92442958 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557192328 | chr5:92442991-92442992 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189441495 | chr5:92443033-92443034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs545992440 | chr5:92443039-92443040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs559518818 | chr5:92443045-92443046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192443160 | chr5:92443069-92443070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs79112835 | chr5:92443083-92443084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146734945 | chr5:92443086-92443087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13188341 | chr5:92443100-92443101 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs140334214 | chr5:92443121-92443122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113466266 | chr5:92443158-92443159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533010877 | chr5:92443171-92443172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546860568 | chr5:92443275-92443276 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150387733 | chr5:92443322-92443323 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549747562 | chr5:92443343-92443344 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs551961050 | chr5:92443352-92443353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs78172026 | chr5:92443378-92443379 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138086397 | chr5:92443402-92443403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184398518 | chr5:92443497-92443498 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188744958 | chr5:92443573-92443574 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs13177386 | chr5:92443605-92443606 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs561229659 | chr5:92443663-92443664 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs181299173 | chr5:92443702-92443703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576973951 | chr5:92443705-92443706 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:92437400-92443000 | Weak transcription | Stomach Smooth Muscle | stomach |
2 | chr5:92441800-92444000 | Enhancers | Fetal Kidney | kidney |
3 | chr5:92442200-92444200 | Enhancers | Fetal Lung | lung |
4 | chr5:92442200-92444200 | Enhancers | Ovary | ovary |
5 | chr5:92442800-92443800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr5:92442800-92443800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
7 | chr5:92442800-92444200 | Enhancers | Adipose Nuclei | Adipose |
8 | chr5:92443000-92443200 | Enhancers | Stomach Smooth Muscle | stomach |
9 | chr5:92443000-92443600 | Enhancers | Colon Smooth Muscle | Colon |
10 | chr5:92443000-92443800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr5:92443000-92444200 | Enhancers | Fetal Stomach | stomach |
12 | chr5:92443200-92444000 | Weak transcription | Stomach Smooth Muscle | stomach |
13 | chr5:92443600-92444000 | Enhancers | HepG2 | liver |
14 | chr5:92443800-92450800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
15 | chr5:92444000-92444200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr5:92444000-92444200 | Enhancers | Stomach Smooth Muscle | stomach |